Evidence map›Paper›PMID 40903627›Full record

ArticleAAPS PharmSciTech2025

Effects of Roller Compaction on Dissolution of Granules and Tablets Captured in the Development of Two Real Pharmaceutical Formulations.

Nikita Marinko, Stephanie Michelle Medrano, Tomáš Krpelan, Zuzana Chayka, Kateřina Budková, Vít Zvoníček, Petr Zámostný

Abstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nikita MarinkoDepartment of Organic Technology, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 5, 166 28, Prague, Czech Republic. nikita.marinko@zentiva.com.
Stephanie Michelle MedranoDepartment of Organic Technology, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 5, 166 28, Prague, Czech Republic.
Tomáš KrpelanDepartment of Organic Technology, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 5, 166 28, Prague, Czech Republic.
Zuzana ChaykaDepartment of Organic Technology, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 5, 166 28, Prague, Czech Republic.
Kateřina BudkováDepartment of Organic Technology, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 5, 166 28, Prague, Czech Republic.
Vít ZvoníčekZentiva k.s., U Kabelovny 130, 102 00, Prague, Czech Republic.
Petr ZámostnýDepartment of Organic Technology, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 5, 166 28, Prague, Czech Republic. petr.zamostny@vscht.cz.ORCID http://orcid.org/0000-0002-0494-6560

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Roller compaction is often utilized as the first step to improve flow properties and homogeneity of pharmaceutical mixtures. Since the dry granulation process is less complicated than its counterparts in the industry, it is possible to perform screening experiments readily to investigate granulate quality for further operations. In this study, the aim of the investigation focused on the effect of roller compaction on the dissolution of granules and tablets of two pharmaceutical formulations that contain APIs of different biopharmaceutical classification. This study underscores the benefits of granule dissolution testing as a crucial early-stage technique for optimizing granulate quality and facilitating progression through formulation manufacturing operations. For active pharmaceutical ingredients characterized by poor dissolution properties, this approach provides valuable insights during the initial development phases. By integrating granule dissolution testing into the development process, product manufacturability can be enhanced and optimal product performance can be ensured.

Indexed as

Drug CompoundingDrug LiberationTabletsBenzhydryl CompoundsChemistry, PharmaceuticalExcipientsGlucosidesGlycyrrhizic AcidPowdersSimvastatinSolubilityBenzhydryl CompoundsdapagliflozinExcipientsGlucosidesGlycyrrhizic AcidPowderssimvaglyzinSimvastatinTabletsDisintegration kineticsDissolution behaviorDissolution rateDry granulationFlow-through cellGranule dissolutionGranule propertiesPaddle dissolutionPoller compactionPorosityProcess engineeringProcess parametersTablet dissolutionUSP2 dissolutionUSP4 dissolution

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.